These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 176608)

  • 1. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC
    Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
    Yamashita Y; Kawai M; Hotta K
    Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445
    [No Abstract]   [Full Text] [Related]  

  • 3. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
    Nahorski SR; Rogers KJ
    Neuropharmacology; 1976 Oct; 15(10):609-12. PubMed ID: 186725
    [No Abstract]   [Full Text] [Related]  

  • 5. The cyclic AMP system and drug development.
    Smith CG
    Adv Enzyme Regul; 1974; 12():187-203. PubMed ID: 4156822
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the catalytic site of adenylate cyclase in the central nervous system by phenothiazine derivatives.
    Palmer GC; Manian AA
    Neuropharmacology; 1974 Jul; 13(7):651-64. PubMed ID: 4155055
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum.
    Palmer GC
    Exp Neurol; 1979 Feb; 63(2):322-35. PubMed ID: 220075
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ethanol on the cyclic AMP system of the dog gastric mucosa.
    Puurunen J; Karppanen H; Kairaluoma M; Larmi T
    Eur J Pharmacol; 1976 Aug; 38(2):275-9. PubMed ID: 182509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal localization of the enhanced adenylate cyclase responsiveness to catecholamines in the rat cerebral cortex following reserpine injections.
    Palmer GC; Wagner HR; Putnam RW
    Neuropharmacology; 1976 Nov; 15(11):695-702. PubMed ID: 187979
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB; Wilkinson RG
    Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cyclic AMP pulses on adenylate cyclase and the phosphodiesterase inhibitor of D. discoideum.
    Klein C; Darmon M
    Nature; 1977 Jul; 268(5615):76-8. PubMed ID: 196203
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

  • 14. An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase.
    Wallace RW; Lynch TJ; Tallant EA; Cheung WY
    Arch Biochem Biophys; 1978 Apr; 187(2):328-34. PubMed ID: 208465
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 16. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
    Hunt NH; Evans T
    Biochim Biophys Acta; 1980 Jun; 613(2):499-506. PubMed ID: 6256001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex.
    Ye Y; O'Donnell JM
    J Neurochem; 1996 May; 66(5):1894-902. PubMed ID: 8780016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
    Reynolds CH; Claxton PT
    Biochem Pharmacol; 1982 Feb; 31(3):419-21. PubMed ID: 6280730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents.
    Zhang B; Yang L; Konishi Y; Maeda N; Sakanaka M; Tanaka J
    Neuropharmacology; 2002 Feb; 42(2):262-9. PubMed ID: 11804623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.